A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

A growing number of South Dakotans are shedding pounds thanks to GLP-1 medications, but now they’re hitting a roadblock.

VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...

FROM sulphur burps to diarrhoea and nausea, there are many widely known Ozempic side effects – but there’s also a whole host of nasty long-term issues experts are only just uncovering.

Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look ...

As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.

World Thyroid Day 2025 urges awareness of thyroid disorders, promotes early testing, and highlights treatment and dietary ...

Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...